|
|
|
|
Pumping Iron
Anemia, an often overlooked and undertreated condition, has long been viewed as a nonserious condition, one without major consequence to the health of Americans. Viewpoints have started to shift, however, as public health agencies are beginning to realize the significant impact anemia has on health care in our nation.
|
| |
More>>
|
|
|
|
|
|
Active education helps prevent antibiotic misuse
Reducing excessive or inappropriate antibiotic use is the best way to slow down the spread of antimicrobial resistance in bacterial infections. A report examining dozens of studies of quality-improvement (QI) interventions found that actively engaging the clinician in workshops or educational outreach on antibiotic treatment appears to be more effective than simply posting signs about correct/incorrect antibiotic use.
|
| |
More>>
|
|
|
|
|
|
Pharmacoeconomics a key in ICU drug choice
There is more to choosing drugs for the intensive care unit than cost. How effective a particular agent is may be even more important than how much it costs. "Pharmaceuticals are not cheap, especially not in the ICU," said Joseph Dasta, pharmacy professor at Ohio State University College of Pharmacy.
|
| |
More>>
|
|
|
|
|
|
New drug may reduce need for transfusions in MDS
Celgene Corp., Summit, N.J., recently received Food & Drug Administration approval for lenalidomide (Revlimid) for the treatment of patients with transfusion-dependent anemia due to low- or intermediate-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. MDS is a group of hematologic disorders in which the bone marrow does not function normally, producing immature cells that may result in anemia, neutropenia, and/or thrombocytopenia.
|
| |
More>>
|
|
|
We subscribe to the HONcode principles of the Health On the Net Foundation